Search Within

Elisa De Stanchina

  1. "Blood"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (4)
Groups
  1. Center for Hematologic Malignancies (15)
  2. GSK Faculty (14)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (11)
  4. Department of Medicine (11)
  5. Executive Committee, Center for Hematologic Malignancies (11)
  6. Hematologic Malignancies, Division of (11)

More Groups

People
  1. Anas Younes (4)
  2. Venkatraman Seshan (4)
  3. Qing Chang (3)
  4. Ross Levine (3)
  5. Scott Lowe (3)
  6. Zahra Asgari (3)

More People

Years
  1. 2024 (1)
  2. 2022 (2)
  3. 2021 (1)
  4. 2019 (1)
  5. 2017 (1)
  6. 2016 (4)

More Years

Publications
  1. Blood (16)
Publishers
  1. American Society of Hematology (16)

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Development of CAR T cells targeting U5 snRNP200 for the treatment of acute myeloid and B-lymphoid leukemias
    Meeting Abstract

    Fujino, T.; Lewis, J.; Chen, B. Y.; Sievers, Q.; Cai, W.; Yoo, S.; Mathew, S.; Souness, S.; Burns, E. R.; Um, J. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Target densities in malignant and normal cells determine CAR T cell efficacy and off-target hematotoxicity
    Meeting Abstract

    Haubner, S.; Mansilla-Soto, J.; Nataraj, S.; Kogel, F.; Chang, Q.; De Stanchina, E.; Fraser, K.; Park, J. H.; Wang, X.; RivieĢ€re, I.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Overcoming heterogeneity in AML with a novel or-gated HITCAR-1XX platform
    Meeting Abstract

    Haubner, S.; Mansilla-Soto, J.; Garcia Angus, A.; Chang, Q.; De Stanchina, E.; Sadelain, M.
    Blood (2022)

    Fulltext@MSK | Save
  • Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition
    Journal Article

    Bala Tannan, N.; Manzari, M. T.; Herviou, L.; Da Silva Ferreira, M.; Hagen, C.; Kiguchi, H.; Manova-Todorova, K.; Seshan, V.; de Stanchina, E.; Heller, D. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Dual inhibition of MCL1 and BCL2 in lymphoma using tumor targeted nanoparticles
    Meeting Abstract

    Bala, N. B.; Taghizadeh Manzari, M.; Da Silva Ferreira, M.; Asgari, Z.; Hagen, C.; Seshan, V.; de Stanchina, E.; Manova-Todorova, K.; Heller, D.; Younes, A.
    Blood (2019)

    Fulltext@MSK | Save
  • Generation and application of T-cell lymphoma patient derived tumor xenograft models
    Meeting Abstract

    Fiore, D.; Wang, X.; Khodos, I.; Di Giacomo, F.; Gaudiano, M.; Phillip, J. M.; Wang, R.; Yang, Z.; Ginsberg, M.; Intlekofer, A. M.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
    Meeting Abstract

    Mondello, P.; Derenzini, E.; Asgari, Z.; Philip, J.; Brea, E. J.; Seshan, V. E.; Hendrickson, R.; de Stanchina, E.; Scheinberg, D. A.; Younes, A.
    Blood (2016)

    Fulltext@MSK | Save
  • MYC-dependent PI3K and MCL-1 feedbacks attenuate BET inhibitors activity in diffuse large B-cell lymphoma
    Meeting Abstract

    Derenzini, E.; Mondello, P.; Liu, Y.; Scallion, M.; Asgari, Z.; Philip, J.; Hilden, P.; Djaballah, H.; Ouerfelli, O.; de Stanchina, E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Peptidomimetic blockade of MYB in acute myeloid leukemia
    Meeting Abstract

    Ramaswamy, K.; Forbes, L.; Brown, F. C.; Koche, R.; Gindin, T.; Minuesa, G.; Kharas, M. G.; Krivtsov, A.; Armstrong, S. A.; Still, E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A pharmacologically reversible epigenomic signature of relapse and chemotherapy resistance in anaplastic large cell lymphoma
    Meeting Abstract

    Pan, H.; Gaudiano, M.; Tabbo, F.; de Stanchina, E.; Martin, P.; Elemento, O.; Inghirami, G.
    Blood (2016)

    Fulltext@MSK | Save